Filter by Category: Antimicrobial Surveillance

Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs: A 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.

Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: A 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group. by Jones RN, Pfaller MA, Doern GV, Erwin ME and Hollis RJ published in Diagn. Microbiol. Infect. Dis. 1998; 30 (3): 215-228

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. by Jones RN, Ballow CH, Biedenbach DJ, Deinhart JA and Schentag JJ published in Diagn. Microbiol. Infect. Dis. 1998; 31 (3): 437-451

Comparative antimicrobial activity of trovafloxacin tested against 3,049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.

Comparative antimicrobial activity of trovafloxacin tested against 3,049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season. by Jones RN, Pfaller MA and Doern GV published in Diagn. Microbiol. Infect. Dis. 1998; 32 (2): 119-126

Antimicrobial activity of gatifloxacin tested against 1,676 strains of ciprofloxacin-resistant Gram-positive cocci isolated from patient infections in North and South America.

Antimicrobial activity of gatifloxacin tested against 1,676 strains of ciprofloxacin-resistant Gram-positive cocci isolated from patient infections in North and South America. by Jones RN, Beach ML, Pfaller MA and Doern GV published in Diagn. Microbiol. Infect. Dis. 1998; 32 (3): 247-252

Multicenter evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group.

Multicenter evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group. by Doern GV, Jones RN, Pfaller MA, Erwin M and Ramirez-Rhonda C published in Diagn. Microbiol. Infect. Dis. 1998; 30 (2): 113-119

Antimicrobial susceptibility of Klebsiella pneumoniae producing extended-spectrum β-lactamase (ESBL) isolated in hospitals in Brazil.

Antimicrobial susceptibility of Klebsiella pneumoniae producing extended-spectrum beta-lactamase (ESBL) isolated in hospitals in Brazil. by Gales AC, Bolmstrom A, Sampaio J, Jones RN and Sader HS published in Braz. J. Infect. Dis. 1997; 1 (4): 196-203

Inducible Amp-C β-lactamase producing Gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).

Inducible Amp-C β-lactamase producing Gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). by Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB and Wenzel RP published in Diagn. Microbiol. Infect. Dis. 1997; 28 (4): 211-219

Antimicrobial interactions (synergy) of teicoplanin with two broad-spectrum drugs (cefotaxime, ofloxacin) tested against Gram-positive isolates from Germany and the United States.

Antimicrobial interactions (synergy) of teicoplanin with two broad-spectrum drugs (cefotaxime, ofloxacin) tested against Gram-positive isolates from Germany and the United States. by Jones RN, Marshall SA and Grimm H published in Diagn. Microbiol. Infect. Dis. 1997; 29 (2): 87-94

Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.

Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group. by Jones RN, Salazar JC, Pfaller MA and Doern GV published in Diagn. Microbiol. Infect. Dis. 1997; 29 (4): 265-272

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients.

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. by Jones RN published in Am. J. Med. 1996; 100 (6A): 3S-12S